Latest Bacil Pharma stock price
Bacil Pharma P/E Ratio
BACPHAR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
63.61
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
63.61
Current Price
₹40.71
EPS (TTM)
₹0.64
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.4
Sector Median
31.12
Sector Rank
#11 of 132
Sector Percentile
8.3%
Key P/E Ratio Insights for Bacil Pharma
- Stock appears overvalued with PE of 63.61, suggesting caution for new investments
- Trading at premium to sector average PE of 53.4
View the BACPHAR equity price for detailed stock performance.
Related Pages for Bacil Pharma
Additional stock information and data for BACPHAR
Sector P/E Ratio Comparison
Comparing Bacil Pharma with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |